Case Study
Apilotrandomizedcontrolledtrialof7 versus14daysofantibiotictreatmentfor bloodstreaminfectiononnon-intensive careversusintensivecarewards
Apilotrandomizedcontrolledtrialof7 versus14daysofantibiotictreatmentfor bloodstreaminfectiononnon-intensive careversusintensivecarewards
RESEARCH Open Access A pilot randomized controlled trial of 7 versus 14days of antibiotic treatment for bloodstream infection on non-intensive care versus intensive care wards Nick Daneman 1* , Asgar H. Rishu 2 , Ruxandra Pinto 2 , Yaseen Arabi 3 , Emilie P. Belley-Cote 4 , Robert Cirone 5 , Mark Downing 6 , Deborah J. Cook 7 , Richard Hall 8 , Shay McGuinness 9 , Lauralyn McIntyre 10 , John Muscedere 11 , Rachael Parke 9,12 , Steven Reynolds 13 , Benjamin A. Rogers 14 , Yahya Shehabi 15 , Phillip Shin 16 , Richard Whitlock 17 , Robert A. Fowler 18* and on behalf of the Canadian Critical Care Trials Group Abstract Background: The optimal treatment duration for patients with bloodstream infection is understudied. The Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (B